TrueTicker

NIFTY 500 › Chemicals

Chemicals · NIFTY 500

Deepak Nitrite Ltd.

DEEPAKNTR on NSE · 19 Nov 2026

NIFTY 500

1,552.30 ▼ -0.68 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Options Guidance & governance

Filings

28 filings of DEEPAKNTR since November 2024.

transcript 9, presentation 7, board outcome 7, results 2, dividend 2, credit rating 1

FiledTypeSubject
04 Nov 2026transcript
Capex, Guidance, Results
Deepak Nitrite Limited has informed the Exchange about Transcript
AI summary

Filing submits the transcript of Deepak Nitrite's Q2 & H1 FY27 earnings conference call held on October 30, 2026.

Management (Maulik Mehta) said Q2 FY27 consolidated revenue from operations was INR 3,091 crore (61% YoY, 19% QoQ) and EBITDA was a record INR 643 crore with a 21% margin; PAT was INR 398 crore.

CFO Sanjay Upadhyay said H1 FY27 consolidated revenue was INR 5,682 crore, EBITDA INR 1,197 crore and PAT INR 743 crore.

Phenolics quarterly revenue was a record INR 2,291 crore with EBIT of INR 515 crore; Advanced Intermediates Q2 EBIT was INR 49 crore (6% margin) versus INR 67 crore in Q1.

Management said net debt was INR 1,657 crore and net debt-to-equity 0.25x; it expects Q3 AI EBIT margin near Q1 levels, with Q4 better than Q3.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
29 Oct 2026presentation
Capex, Guidance, Results
Deepak Nitrite Limited has informed the Exchange about General Updates- Q2 & H1 FY2027 Results Presentation
AI summary

Q2 FY27 consolidated revenue ₹3,091 crore (+61% YoY, +19% QoQ), EBITDA ₹643 crore (+187% YoY), PAT ₹398 crore (+235% YoY).

H1 FY27 consolidated revenue ₹5,682 crore (+48% YoY), EBITDA ₹1,197 crore (+173% YoY), PAT ₹743 crore (+221% YoY).

Management said Phenolics delivered record H1 EBIT of ₹933 crore, driven by supply-chain integration and procurement efficiencies, and the Group posted its highest-ever quarterly and first-half performance.

Management said Advanced Intermediates recalibrated towards volume-led growth, with Q2 revenue up 72% YoY to ₹2,291 crore and EBIT up 256% YoY to ₹515 crore, though profitability was pressured by aggressive global pricing and higher raw material and freight costs.

Management expects the Phenolics advantage to continue until the market stabilises to a new normal, and cites upcoming projects as supporting future growth.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
29 Oct 2026board outcome
Results
Deepak Nitrite Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
AI summary

The Board of Directors approved the standalone and consolidated un-audited financial results for the quarter and half year ended 30 September 2026, at a meeting held on 29 October 2026.

The results were signed by the Chairman and Managing Director and are enclosed with a limited review report from Deloitte Haskins & Sells LLP, the statutory auditors.

The Board meeting commenced at 2:00 P.M. and concluded at 4:00 P.M.

The filing does not state any figures for revenue, profit or dividend.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
11 Aug 2026transcript
Capex, Guidance, Results
Deepak Nitrite Limited has informed the Exchange about Transcript
AI summary

Deepak Nitrite filed the transcript of its Q1 & FY2027 earnings conference call held on August 6, 2026.

Management said Q1 FY27 consolidated revenue from operations was INR 2,592 crore (up 35% year-on-year, 22% sequentially), EBITDA INR 554 crore (margin 21%), PBT INR 468 crore and PAT INR 345 crore, described as record levels.

Management said Phenolics revenue was INR 1,775 crore with record EBIT of INR 418 crore, and Advanced Intermediates revenue was INR 804 crore with EBIT of INR 67 crore.

Management said the ammonia-to-amines integration chain has been commissioned and stabilised, and MIBK and MIBC are to be commissioned along with acetophenone in August 2026.

Management said debt funding for the INR 11,500 crore propylene and polycarbonate project (debt:equity 60:40) has been tied up, and consolidated net worth was INR 6,214 crore with debt-to-equity of 0.27x.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
04 Aug 2026presentation
Capex, Guidance, Results
Deepak Nitrite Limited has informed the Exchange about General Updates -Q1 FY 2027 Investor Presentation
AI summary

Deepak Nitrite filed its Q1 FY2027 results presentation dated 4 August 2026, describing it as the highest-ever quarterly performance.

Consolidated revenue for Q1 FY27 was ₹2,592 crore, up 35% year-on-year and 22% quarter-on-quarter.

Consolidated EBITDA was ₹554 crore, up 159% year-on-year and 45% quarter-on-quarter; PAT was ₹345 crore, up 207% year-on-year and 57% quarter-on-quarter.

Management said the company is focused on import substitution under Atmanirbhar Bharat, a planned integrated polycarbonate plant of 165,000 MT/yr, and a shift of 60–70% of energy requirements to green sources.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
04 Aug 2026board outcome
Results
Deepak Nitrite Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
AI summary

Deepak Nitrite Limited's board approved standalone and consolidated un-audited financial results for the quarter ended 30 June 2026 at a meeting held on 4 August 2026, and filed them under Regulation 33 of the Listing Regulations with a limited review report from Deloitte Haskins & Sells LLP.

Consolidated total income for the quarter ended 30 June 2026 was Rs 2,577.60 crore, against Rs 2,120.33 crore in the quarter ended 31 March 2026 and Rs 1,889.88 crore in the quarter ended 30 June 2025 (figures as printed in the filing).

Consolidated net profit for the quarter ended 30 June 2026 was Rs 467.63 crore, against Rs 301.35 crore in the quarter ended 31 March 2026 and Rs 154.74 crore in the quarter ended 30 June 2025.

Standalone revenue from operations for the quarter ended 30 June 2026 was Rs 806.76 crore, and standalone net profit was Rs 64.27 crore; the filing does not contain a management commentary on the outlook.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
22 May 2026transcript
Capex, Dividend / buy-back, Guidance, Results
Deepak Nitrite Limited has informed the Exchange about Transcript
AI summary

Deepak Nitrite filed the transcript of its Q4 & FY26 earnings conference call held on May 18, 2026.

Management said Q4 FY26 consolidated revenue was INR2,127 crore, EBITDA was INR383 crore (18% margin) and PAT was INR220 crore; FY26 consolidated revenue was INR7,947 crore, EBITDA INR1,041 crore and PAT INR551 crore.

Management said Phenolics Q4 revenue was INR1,429 crore with EBIT of INR287 crore, and Advanced Intermediates Q4 revenue was INR708 crore with EBIT of INR34 crore.

The Board recommended a final dividend of INR7.5 per equity share for FY26.

On nitric acid, management said the plant ran at about 45% utilization in Q4 due to technical issues; MIBK/MIBC commissioning is expected around the end of Q1 or early Q2 FY27, and new products are expected on commercial production from Q3.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
15 May 2026presentation
Capex, Results
Deepak Nitrite Limited has informed the Exchange about General Updates - Q4 & FY2026 Results Presentation
AI summary

Deepak Nitrite reported Q4 FY26 consolidated total revenue of ₹2,127 crore (down 3% Y-o-Y, up 7% Q-o-Q), EBITDA of ₹383 crore (up 74% Q-o-Q, up 13% Y-o-Y) and PAT of ₹220 crore (up 9% Y-o-Y).

For FY26, total revenue was ₹7,947 crore (down 5% from ₹8,366 crore in FY25), EBITDA ₹1,041 crore (down 11%) and PAT ₹551 crore (down 21%).

FY26 PBT is stated as ₹770 crore, before exceptional gratuity provision expenses of ₹11.31 crore in Advanced Intermediates and ₹1.53 crore in Phenolics.

Management said the company delivered a strong performance despite volatility, supply chain disruption and geopolitical events, citing steady domestic demand, pricing gains and cost efficiencies.

Management also cited a new R&D Centre with ₹100 crore investment, commissioning of a Nitration and 2nd Hydrogenation Plant at Dahej, and FX gains of about ₹12 crore in FY26.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
15 May 2026dividend
Dividend / buy-back
Deepak Nitrite Limited has informed the Exchange that Board of Directors at its meeting held on May 15, 2026, recommended Final Dividend of Rs. 7.5 per equity share.
AI summary

The Board of Directors of Deepak Nitrite Limited, at its meeting held on 15 May 2026, recommended a final dividend of Rs 7.50 per equity share (375%) for the year ended 31 March 2026.

The dividend is on 13,63,93,041 equity shares of face value Rs 2 each.

The dividend is subject to shareholder approval at the 55th Annual General Meeting (AGM).

If approved, the dividend will be paid within 30 days from the date of the AGM.

The Board meeting commenced at 2:10 P.M. and concluded at 4:30 P.M.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
15 May 2026board outcome
Results
Deepak Nitrite Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
AI summary

Deepak Nitrite Limited's board approved audited standalone and consolidated financial results for the year ended 31 March 2026 at its meeting held on 15 May 2026.

The Statutory Auditors, Deloitte Haskins & Sells LLP, issued an audit report with unmodified opinion on both the standalone and consolidated results.

Consolidated revenue from operations for FY2026 was ₹7,887.07 crore, compared with ₹8,281.93 crore in FY2025.

Consolidated net profit for FY2026 was ₹190.71 crore, compared with ₹228.33 crore in FY2025 (net profit attributable to owners of the company as printed in the consolidated statement: ₹190.71 crore for the year).

The board meeting commenced at 2:10 p.m. and concluded at 4:30 p.m.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
18 Feb 2026transcript
Capex, Dividend / buy-back, Guidance, Legal, Results
Deepak Nitrite Limited has informed the Exchange about Transcript
AI summary

Deepak Nitrite filed the transcript of its Q3 & 9M FY26 earnings conference call held on February 13, 2026.

Management said Q3 FY26 consolidated total revenue was INR 1,983 crore (up 3% YoY and QoQ) and EBITDA was INR 219 crore (up 16% YoY), with EBITDA margin at 11% versus 10%.

For 9M FY26, management reported consolidated revenue of INR 5,820 crore, EBITDA of INR 658 crore and PAT of INR 331 crore, citing pricing pressure and margin compression in select product lines.

Management said Phenolics EBIT was INR 145 crore in Q3 (up 20% YoY) and Advanced Intermediates EBIT was INR 15 crore on revenue of INR 652 crore, hit by Chinese dumping and global oversupply.

Management said the polycarbonate project funding tie-up is at the final stage, the MIBK/MIBC project is targeted for commissioning in the current quarter, and it expects a favourable performance in Q4 FY26.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
12 Feb 2026presentation
Capex, Guidance, Legal, Results
Deepak Nitrite Limited has informed the Exchange regarding 'DNL-Q3FY26ResultsPresentation'.
AI summary

Deepak Nitrite filed its Q3 and 9M FY2026 results presentation dated 12 February 2026 (consolidated).

Q3 FY26 revenue was ₹1,983 crore (up 3% YoY, down 3% QoQ from ₹1,922 crore); EBITDA was ₹219 crore (up 16% YoY); PBT was ₹151 crore before a one-time exceptional item of ₹12.84 crore for gratuity provision under the new Labour codes.

9M FY26 revenue was ₹5,820 crore (down 6% YoY) and EBITDA was ₹658 crore (down 21% YoY).

Management said Advanced Intermediates faces aggressive Chinese dumping and overcapacity, while Phenolics performed consistently; it expects a favorable Q4 FY26 and cited the removal of the 45.16% US anti-dumping duty on sodium nitrite exports as a positive.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
12 Feb 2026board outcome
Results
Deepak Nitrite Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
AI summary

Deepak Nitrite's board approved the standalone and consolidated unaudited financial results for the quarter and nine months ended 31 December 2025 at a meeting held on 12 February 2026, with a limited review report from Deloitte Haskins & Sells LLP attached.

Consolidated revenue from operations for the quarter ended 31.12.2025 was ₹1,974.97 crore, against ₹1,901.89 crore in the quarter ended 31.12.2024 (as printed in the table).

Consolidated profit before tax for the quarter ended 31.12.2025 was ₹137.97 crore, and for the nine months ended 31.12.2025 was ₹455.74 crore (as printed).

Standalone revenue from operations for the quarter ended 31.12.2025 was ₹693.59 crore (as printed).

The filing contains no management commentary or outlook on the business.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
20 Nov 2025transcript
Capex, Guidance, Results
Deepak Nitrite Limited has informed the Exchange about Transcript
AI summary

Deepak Nitrite filed the transcript of its Q2 & H1 FY26 earnings conference call held on November 14, 2025.

Management reported Q2 FY26 consolidated revenue of INR 1,922 crore (up from INR 1,914 crore in Q1) and EBITDA of INR 224 crore (up 5% sequentially), with PAT of INR 119 crore.

H1 FY26 consolidated revenue was INR 3,836 crore versus INR 4,239 crore in H1 FY25, and EBITDA was INR 438 crore versus INR 647 crore.

Management said Phenolics revenue rose 2% sequentially to INR 1,333 crore with EBIT up 23%, while Advanced Intermediates faced tariff and underpricing pressure with Q2 EBIT of INR 23 crore.

Management said the Savli R&D centre (about INR 100 crore) and the Chem Tech hydrogenation asset (about INR 118 crore, commenced September 26, 2025) are operational, and that nitric acid and MIBK/MIBC plants are expected to be commissioned soon.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
13 Nov 2025presentation
Capex, Guidance, Results
Deepak Nitrite Limited has informed the Exchange about Investor Presentation
AI summary

Deepak Nitrite's Q2 & H1 FY2026 results presentation, dated 13 November 2025.

Q2 FY26 total revenue was ₹1,922 crore (Q2 FY25: ₹2,053 crore, down 6% YoY) and EBITDA was ₹224 crore (down 30% YoY); PBT was ₹163 crore (down 38% YoY).

H1 FY26 revenue was ₹3,836 crore (down 9% YoY), EBITDA ₹438 crore (down 32% YoY) and PBT ₹318 crore (down 41% YoY).

Management said the near-term outlook remains challenging, with H2 performance expected to improve on ramp-up of new capacities, while US tariffs and Chinese imports constrain the Advanced Intermediates business.

Acid unit expected to be fully operational by Q4 FY26; MIBK/MIBC project targeted for commissioning by end of Q4 FY26.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
12 Nov 2025board outcome
Results
Deepak Nitrite Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
AI summary

Deepak Nitrite Limited filed its standalone and consolidated unaudited financial results for the quarter and half year ended 30 September 2025, approved by the board on 12 November 2025.

Standalone: quarter ended 30.09.2025 revenue from operations Rs 615.92 crore and net profit Rs 111.65 crore; half year revenue from operations Rs 1,228.20 crore and net profit Rs 141.95 crore.

Consolidated: quarter ended 30.09.2025 revenue from operations Rs 1,901.89 crore and net profit Rs 118.75 crore; half year revenue from operations Rs 3,791.77 crore and net profit Rs 231.01 crore.

Consolidated basic and diluted EPS for the quarter ended 30.09.2025 was Rs 8.71 (face value Rs 2), against Rs 14.24 a year earlier.

Limited review report issued by Deloitte Haskins & Sells LLP was enclosed as required under Regulation 33 of the Listing Regulations.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
21 Aug 2025transcript
Capex, Guidance, Results
Deepak Nitrite Limited has informed the Exchange about Transcript
AI summary

Deepak Nitrite filed the transcript of its Q1 FY26 earnings conference call held on August 14, 2025.

Management reported Q1 FY26 consolidated revenue of INR 1,897 crore, EBITDA of INR 197 crore (10% margin, up 11% quarter-on-quarter) and PBT of INR 138 crore (up 17% quarter-on-quarter), all excluding government incentives of INR 17 crore.

Management said the Advanced Intermediates segment faced subdued agrochemical intermediate demand and that a recovery is expected in the upcoming period, while Phenolics delivered revenue of INR 1,287 crore with EBIT of INR 101 crore.

Management said it plans investments of around INR 10,000 crore over the next 3 years and that the polycarbonate integrated complex is expected to start commercial operations by December 2027.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
13 Aug 2025presentation
Capex, Guidance, Rating, Results
Deepak Nitrite Limited has informed the Exchange about General Updates - Q1 FY2026 Investor Presentation
AI summary

Deepak Nitrite filed its Q1 FY2026 results presentation dated August 13, 2025, reporting Total Income of ₹1,897 crore and EBITDA of ₹197 crore for Q1 FY26.

The presentation gives FY25 revenue of ₹8,282 crore, EBITDA of ₹1,176 crore (14% margin), RoCE of 14% and net worth of ₹5,389 crore.

ICRA has assigned a long-term rating of AA Stable and a short-term rating of A1+, as stated in the presentation.

Management notes a ₹8,500 crore Polycarbonate plant (165,000 MT/yr) expected to be commissioned by FY28 and MIBK/MIBC units expected by H2 FY26.

Management also cites a ₹10,000 crore investment plan for specialty chemicals and import-substitute products.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
13 Aug 2025board outcome
Results
Deepak Nitrite Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
AI summary

Deepak Nitrite Limited filed its Standalone and Consolidated Un-audited Financial Results for the quarter ended 30 June 2025, approved by the Board at its meeting held on 13 August 2025.

The Board meeting commenced at 2:30 P.M. and concluded at 4:40 P.M. on 13 August 2025.

Statutory auditor Deloitte Haskins & Sells LLP issued limited review reports on both the standalone and consolidated results, with no modification to its conclusion.

The limited review report notes that 3 subsidiaries (total revenue Rs. 11.17 Crores, net loss after tax Rs. 3.10 Crores) were reviewed by other auditors, and 2 subsidiaries (total revenue Rs. 0.07 Crores, loss after tax Rs. 0.06 Crores) were not reviewed by their auditors.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
11 Aug 2025credit rating
Rating
Deepak Nitrite Limited has informed the Exchange about Credit Rating
AI summary

ICRA Limited reaffirmed Deepak Nitrite Limited's long-term rating at [ICRA] AA and short-term rating at [ICRA] A1+ for Rs 490.00 Crores bank facilities and Rs 200.00 Crores Commercial Paper; long-term outlook revised to Stable from Positive.

ICRA reaffirmed Deepak Phenolics Limited (wholly owned subsidiary) long-term rating at [ICRA] AA and short-term rating at [ICRA] A1+ for Rs 729.02 Crores bank facilities; outlook revised to Stable from Positive.

ICRA reaffirmed Deepak Chem Tech Limited (wholly owned subsidiary) long-term rating at [ICRA] A and short-term rating at [ICRA] A2+ for Rs 200.00 Crores bank facilities; outlook is Stable.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
03 Jun 2025transcript
Capex, Dividend / buy-back, Guidance, Results
Deepak Nitrite Limited has informed the Exchange about Transcript
AI summary

Deepak Nitrite filed the transcript of its Q4 & FY25 earnings conference call held on May 29, 2025.

Management reported FY25 consolidated revenue of INR 8,366 crore (up 8% from INR 7,758 crore), EBITDA of INR 1,176 crore at a 14% margin, PBT of INR 953 crore and PAT of INR 697 crore.

Q4 FY25 consolidated total income was INR 2,202 crore, EBITDA INR 339 crore and PAT INR 202 crore; Q4 EBITDA was partly supported by government incentives, which management said were INR 161 crore accumulated.

Management declined to give sharp guidance for the next two quarters owing to geopolitical uncertainty but remains confident of optimistic full-year FY26 growth; it expects several projects to commission in phases during FY26.

The Board maintained a dividend of INR 7.5 per equity share (375%), and the Board approved an investment of INR 3,500 crore for new phenol, acetone and IPA capacity, taking the total PC resins project investment to about INR 8,500 crore.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
28 May 2025dividend
Dividend / buy-back
Deepak Nitrite Limited has informed the Exchange that Board of Directors at its meeting held on May 28, 2025, recommended Final Dividend of Rs. 7.5 per equity share.
AI summary

Board of Directors of Deepak Nitrite Limited, at its meeting held on 28 May 2025, recommended a final dividend of Rs 7.50 per equity share (375%) on face value Rs 2 per share, for the year ended 31 March 2025.

The dividend is on 13,63,93,041 equity shares and is subject to approval by shareholders at the 54th Annual General Meeting.

If approved at the AGM, the dividend will be paid within 30 days from the date of the AGM.

The Board meeting commenced at 2:10 P.M. and concluded at 4:00 P.M.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
28 May 2025board outcome
Results
Deepak Nitrite Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
AI summary

Deepak Nitrite Limited filed the outcome of its board meeting held on 28 May 2025, which approved the audited standalone and consolidated financial results for the year ended 31 March 2025.

The filing encloses the audited standalone and consolidated results with the auditor's report from Deloitte Haskins & Sells LLP, Statutory Auditors.

The auditors issued an unmodified opinion on both the annual standalone and consolidated financial results.

The board meeting commenced at 2:10 P.M. and concluded at 4:00 P.M.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
21 Feb 2025transcript
Acquisition, Capex, Guidance, Results
Deepak Nitrite Limited has informed the Exchange about Transcript
AI summary

Deepak Nitrite filed the transcript of its Q3 & 9M FY25 earnings conference call held on February 17, 2025.

Management said Q3 consolidated revenue was Rs. 1,924 crore, down 5% year-on-year, and EBITDA was Rs. 190 crore versus Rs. 318 crore a year earlier; PBT was Rs. 135 crore and PAT Rs. 98 crore.

Management attributed the weakness to deferred agrochemical intermediate demand, customer destocking, higher raw material costs, a Phenolics plant maintenance shutdown and project delays, and expects recovery from Q4 and Q1 onwards.

Management said Advanced Intermediates EBIT was Rs. 17 crore (3% margin) and Phenolics EBIT was Rs. 121 crore (9% margin) in Q3, and that the nitric acid complex is in commissioning with an estimated margin expansion of Rs. 70-80 crore annualised.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
13 Feb 2025presentation
Guidance, Rating, Results
Deepak Nitrite Limited has informed the Exchange regarding 'Q3 & 9M FY 2025 Investor Presentation '.
AI summary

Deepak Nitrite filed its Q3 and 9M FY2025 results presentation dated February 13, 2025.

Total income was ₹6,163 crore and EBITDA was ₹836 crore in 9M FY25; the key numbers slide shows 10% YoY growth in revenue, a 5% YoY contraction in EBITDA for 9M FY25, and a 84:16 domestic to export revenue mix.

Management said the quarter's operating performance was "aberrant", citing idled plants due to deferred demand, lagged recovery in agrochemical intermediates, elevated raw material prices and oversupply from China.

Management expects margin expansion in the current quarter, sees volume pickup from international agrochemical customers from this quarter, and expects domestic customers to start lifting by quarter end.

ICRA rating shown in the presentation: AA (Positive) long-term and A1+ short-term.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
13 Feb 2025results
Results
Integrated Filing - Financial
AI summary

Deepak Nitrite Limited filed its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, under SEBI circular requirements, with the NSE.

Consolidated revenue from operations for the quarter ended 31.12.2024 was ₹1,903.40 crores, against ₹2,009.23 crores in the year-ago quarter; for the nine months it was ₹6,102.24 crores against ₹7,681.83 crores for the year ended 31.03.2024.

Consolidated profit before tax for the quarter ended 31.12.2024 was ₹135.20 crores, against ₹273.59 crores in the year-ago quarter; for the nine months it was ₹674.03 crores against ₹1,101.72 crores for the year ended 31.03.2024.

Consolidated net profit for the quarter ended 31.12.2024 was ₹134.72 crores... see note: basic and diluted EPS for the quarter was ₹9.80 per share (consolidated), not annualised.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
13 Feb 2025results
Results
Deepak Nitrite Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
AI summary

Deepak Nitrite Limited's board approved the standalone and consolidated unaudited financial results for the quarter and nine months ended 31 December 2024 at a meeting held on 13 February 2025.

Consolidated revenue from operations for the quarter ended 31.12.2024 was ₹1,903.40 crores, against ₹2,032.00 crores in the quarter ended 31.12.2023 as printed in the segment table.

Consolidated profit before tax for the quarter ended 31.12.2024 was ₹135.20 crores, against ₹264.03 crores for the corresponding quarter of the previous year.

Consolidated revenue from operations for the nine months ended 31.12.2024 was ₹6,102.24 crores, and consolidated profit before tax was ₹674.03 crores.

The filing includes a limited review report from Deloitte Haskins & Sells LLP, the statutory auditors.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy
21 Nov 2024transcript
Acquisition, Capex, Guidance, Legal, Results
Deepak Nitrite Limited has informed the Exchange about Transcript
AI summary

Deepak Nitrite filed the transcript of its Q2 & H1 FY25 earnings conference call held on November 14, 2024.

Management said consolidated revenue rose 14% YoY in Q2 to INR 2,053 crore and 18% YoY in H1 to INR 4,239 crore; Q2 EBITDA was INR 319 crore (flat YoY) and H1 EBITDA rose 15% to INR 647 crore.

Management said Q2 PAT was INR 194 crore and H1 PAT was INR 397 crore; the Board of DCTL, a 100% subsidiary, approved a polycarbonate resin project with investment of approximately INR 5,000 crore and a technology licence and acquisition of Trinseo's assets in Stade, Germany (165,000 MTPA).

Management said the company holds liquid surplus of around INR 800 crore, has zero net debt, and will return to the market on funding plans in due course.

Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source.

NSE copy

The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in